To validate the results from the RNA sequencing analysis, we evaluated the effect of NR treatment on senescence markers in the WT and WRN−/− MSCs and in primary fibroblasts derived from healthy control donors and WS patients (Supplementary Table 2) [9]. The gene discussed is WRN; the disease is Werner syndrome.